1996
DOI: 10.1074/jbc.271.33.19810
|View full text |Cite
|
Sign up to set email alerts
|

Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
273
1
3

Year Published

1998
1998
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 413 publications
(282 citation statements)
references
References 53 publications
5
273
1
3
Order By: Relevance
“…Studies with other mediators of apoptotic signaling (such as cytochrome C) or inhibitors of these processes may be useful in determining the precise role of iron in this response and the mechanism of PTP activation in vitro. The in vitro properties of the putative TNFactivated PTP and the recently described involvement of PTP1B in both EGF and insulin signaling pathways (Kenner et al, 1996;Flint et al, 1997;Bandyopadhyay et al, 1997;Liu and Cherno , 1997), supported investigation of a role for PTP1B in TNF action. A protein:protein interaction between tyrosine phosphorylated EGFr and PTP1B was suggested by in vitro coprecipitation studies (Figure 6).…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…Studies with other mediators of apoptotic signaling (such as cytochrome C) or inhibitors of these processes may be useful in determining the precise role of iron in this response and the mechanism of PTP activation in vitro. The in vitro properties of the putative TNFactivated PTP and the recently described involvement of PTP1B in both EGF and insulin signaling pathways (Kenner et al, 1996;Flint et al, 1997;Bandyopadhyay et al, 1997;Liu and Cherno , 1997), supported investigation of a role for PTP1B in TNF action. A protein:protein interaction between tyrosine phosphorylated EGFr and PTP1B was suggested by in vitro coprecipitation studies (Figure 6).…”
Section: Discussionmentioning
confidence: 87%
“…PTP1B has been implicated in the control and modulation of several tyrosine phosphorylation-controlled signaling pathways (Frangioni et al, 1993;Kenner et al, 1996;Wiener et al, 1994;Zhai et al, 1993;Woodford-Thomas et al, 1992) and recent studies suggest a speci®c role for PTP1B modulation of EGFr phosphotyrosine levels through direct association of these proteins in a phosphotyrosinedependent fashion (Flint et al, 1997). Since initial studies suggested membrane-association of a TNFstimulated PTP with properties similar to that of PTP1B, its potential role in dephosphorylation of EGFr was investigated.…”
Section: Resultsmentioning
confidence: 99%
“…For example, tyrosine phosphorylation is a key reaction in the initiation and propagation of insulin action (Myers and White, 1996;White and Kahn, 1994). Thus, PTP1B (Ahmad et al, 1995;Kenner et al, 1996;Kole et al, 1996), LAR (Kulas et al, 1995;Zhang et al, 1996) and PTBa (Lammers et al, 1997;Moller et al, 1995) have been implicated as negative regulators of insulin receptor signaling. Consequently, protein phosphatase inhibitors may have use in the treatment of diabetes and obesity.…”
Section: Introductionmentioning
confidence: 99%
“…Early studies suggest that PTP1B blocks insulininduced S6 peptide phosphorylation and inhibits insulin-induced maturation of Xenopus oocytes (10,41). Intracellular delivery of neutralizing antibodies against PTP1B augments IR and IRS-1 phosphorylation and, conversely, overexpression of PTP1B in transfected cells inhibits IR and IRS-1 phosphorylation (4,24). Recent studies show that PTP1B-deficient mice exhibit hypersensitivity to insulin, suggesting that PTP1B is the major tyrosine phosphatase that regulates IR sensitivity (18,28).…”
mentioning
confidence: 99%